Title:
BENZAZEPINE DERIVATIVE ALCOHOLATE OR CRYSTAL THEREOF
Document Type and Number:
WIPO Patent Application WO/2020/171055
Kind Code:
A1
Abstract:
This invention provides an alcoholate of (S)-N-[(S)-1-hydroxypropan-2-yl]-4-methyl-1-[2-methyl-4-(3-methyl-1H-pyrazol-1-yl)benzoyl]-2,3,4,5-tetrahydro-1H-benzo[b]azepine-4-carboxamide represented by formula (I), or a crystal thereof, which is applicable as an active ingredient of a pharmaceutical drug.
Inventors:
KASUGAI NOBUYOSHI (JP)
NAGAI KAZUSHIGE (JP)
SAITOH YUKIHARU (JP)
NAGAI KAZUSHIGE (JP)
SAITOH YUKIHARU (JP)
Application Number:
PCT/JP2020/006243
Publication Date:
August 27, 2020
Filing Date:
February 18, 2020
Export Citation:
Assignee:
SANWA KAGAKU KENKYUSHO CO (JP)
International Classes:
A61P7/02; A61K31/55; A61P13/02; A61P13/10; A61P43/00; C07D403/10
Domestic Patent References:
WO2014104209A1 | 2014-07-03 |
Other References:
GRIESSER, U. J.: "The Importance of Solvates", POLYMORPHISM: IN THE PHARMACEUTICAL INDUSTRY, 2006, pages 211 - 233, XP055582446
"About standards for new drugs and setting of a test method", PHARMACEUTICAL AFFAIRS BUREAU NOTIFICATION NO. 568, 2001
"About standards for new drugs and setting of a test method", PHARMACEUTICAL AFFAIRS BUREAU NOTIFICATION NO. 568, 2001
Attorney, Agent or Firm:
SAKAMOTO & PARTNERS (JP)
Download PDF: